Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of dexmedetomidine in elderly patients undergoing transurethral prostate surgery
ChiCTR2400080509Phase 4Not yet recruiting
- Sponsor
- Ya'an People's Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in benign prostatic hyperplasia (BPH) (4 arms), sponsored by Ya'an People's Hospital. Primary endpoints: Mean arterial pressure and Postoperative delirium. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ChiCTR2400080509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080509.